Peter-Paul Kint

Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity

Pascal Vranckx, Donald E. Cutlip, Roxana Mehran et al. · EuroIntervention · 2010 · 282 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Intracoronary Heparin Delivery in Humans

Edoardo Camenzind, Peter-Paul Kint, Carlo Di Mario et al. · Circulation · 1995 · 58 citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water.

Pascal Vranckx, Peter-Paul Kint, Marie‐Angèle Morel et al. · PubMed · 2008 · 34 citations

Medicine, Cardiology, Interventional Cardiology +15

Proof-of-concept trial to evaluate haemoglobin based oxygen therapeutics in elective percutaneous coronary revascularisation. Rationale, protocol design and haemodynamic results

Emanuele Meliga, Pascal Vranckx, Evelyn Regar et al. · EuroIntervention · 2008 · 21 citations

Medicine, Cardiology, Surgery +17

Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study

Joanna J. Wykrzykowska, Ascan Warnholtz, Peter De Jaeger et al. · Journal of Thrombosis and Thrombolysis · 2009 · 17 citations · Full text

Medicine, Cardiology, Pharmacology +17